The Royal College of Nursing (RCN) announced that it would continue providing accreditation for nurses offering Long Acting Reversible Contraception (LARC). The announcement follows an internal review which focused on finding a sustainable solution to providing LARC accreditation. LARC covers nurses fitting intrauterine techniques (IUTs) and subdermal contraceptive implants (SDIs). From 1 April 2010 the RCN will provide the accreditation at a cost of £300 for members and £400 for non-members.

For the full story, Click Here

BioRx has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

For the full story, Click Here

With a desire to help women in need, Banner Del E. Webb Medical Center’s nurses trekked to Honduras recently to help teach safer birthing practices. With the generosity of BDWMC employees, the PureHeart Christian Fellowship, which sponsored the trip in conjunction with Helping Mothers and Babies, Inc., and donations from Banner Mesa Boswell School of Nursing students and Banner Del E. Webb Medical Center, Emrick collected enough donations to make 300 birthing and midwife kits.

For the full story, Click Here

Medical Acoustics LLC has announced that its FDA-cleared Lung Flute^®, a diagnostic and therapeutic respiratory medical device, was selected by Popular Science magazine for inclusion in the magazine’s prestigious Best of What’s New (BOWN) awards for 2009. The Lung Flute® is the first respiratory medical device that harnesses the non-invasive power of low frequency sound waves to mobilize deep lung secretions.

Ekkyo(TM), a photomedicine company that develops first-in-class laser-based systems for skin scar prevention and reduction is presented its assessment one year after the commercial launch of EkkyLite(TM). Ekkyo has also set up a national register to log and measure the development of the healing process for each patient treated. This confidential register provides personalised access for each practitioner equipped with an EkkyLite (TM) system.